NLRP3 and atrial fibrillation: However, recent studies have shown that CHIP is associated with an increased risk for incident arrhythmias including AF, potentially mediated by dysfunctional calcium handling, NLRP3 inflammasome activation and IL-6 production, and potentially associated with worse clinical outcomes [19–21].